Resource Center
Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
De-Risking FIH: Integrated Strategies for Rapid Proof-of-Concept
Download43 - 48 of 232 results
On-Demand: Development of Orally Delivered GLP-1 Therapeutics …From Diabetes to Obesity and Beyond
18 July 2024CMC Strategies to Manage the Risks Associated with Accelerated Submission Pathways
30 May 2024Rationalizing the Preclinical-Clinical Hurdle – How to Overcome the Toxicology Exposure Challenge
26 March 2024First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367
12 March 2024Two-Part Phase 1 Study to Evaluate the Taste Profile of Novel Belumosudil Oral Suspensions, Relative Bioavailability, and Food Effect
12 February 2024Pharmacokinetics, Pharmacodynamics and Bioavailability of ACM-001.1 (S-Pindolol Benzoate) in Healthy Volunteers
13 December 2023Learn about Quotient Sciences' services
Where integrated CRDMO services bring therapies to life. Whether it's meeting your first-in-human milestone, confidently advancing your program to proof-of-concept, or providing a trusted supply of clinical trial materials or commercial drug product, learn about Quotient Sciences CRDMO offering and how we can support your next drug program.